Redx gets regulatory nod to restart RXC004 clinical trial

Redx gets regulatory nod to restart RXC004 clinical trial

Submitted by admin on January 23, 2019 - 9:24am
Source: 
Pharmaceutical Business Review
News Tags: 
Redx
MHRA
RXC004
clinical trials
solid tumors
Headline: 
Redx gets regulatory nod to restart RXC004 clinical trial
snippet: 

Redx has secured approval from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to restart a phase 1/2a trial for its cancer candidate RXC004 in advanced solid tumors.

Do Not Allow Advertisers to Use My Personal information